Status:
NOT_YET_RECRUITING
Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection
Lead Sponsor:
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Conditions:
Rheumatoid Arthritis (RA)
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
This clinical trial is designed as a single - arm, open - label, single - center, investigator - initiated early - phase clinical study. The primary objective is to evaluate the safety of UTAA91 injec...
Eligibility Criteria
Inclusion
- Aged ≥18 years (inclusive of the boundary value), with no restriction on gender.
- Expected survival time of at least 3 months.
- Subjects with refractory moderate - to - severe active rheumatoid arthritis who have failed standard treatment or lack effective therapeutic options.
- Meet the requirements for liver and kidney function, as well as cardiopulmonary function.
- Free from severe psychiatric disorders.
- Able to understand the trial and have signed the informed consent form.
Exclusion
- A history of malignant tumors other than relapsed/refractory autoimmune diseases (R/R AID) within 5 years prior to screening.
- Subjects with positive results in virus/syphilis tests.
- Severe cardiac diseases or unstable systemic diseases.
- Active or uncontrollable infections requiring systemic treatment within 7 days before administration; evidence of central nervous system invasion at screening.
- Pregnant or breastfeeding women, female subjects planning to become pregnant within 2 years after cell infusion, or male subjects whose partners plan to become pregnant within 2 years after their cell infusion.
- Subjects who have received CAR - T therapy or other gene - modified cell therapies before screening.
- Subjects who participated in other clinical studies within 1 month before screening.
- Other conditions deemed unsuitable for enrollment by the investigator.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2040
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06982547
Start Date
June 1 2025
End Date
June 1 2040
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430000